Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4EJN

Crystal structure of autoinhibited form of AKT1 in complex with N-(4-(5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)-3-fluorobenzamide

4EJN の概要
エントリーDOI10.2210/pdb4ejn/pdb
分子名称RAC-alpha serine/threonine-protein kinase, N-(4-{5-[3-(acetylamino)phenyl]-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl}benzyl)-3-fluorobenzamide, 2-BUTANOL, ... (5 entities in total)
機能のキーワードakt1, autoinhibition, allosteric inhibitor, kinase inhibitor, hydrophobic collapase, kinase, atpase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm: P31749
タンパク質・核酸の鎖数1
化学式量合計52453.83
構造登録者
Eathiraj, S. (登録日: 2012-04-06, 公開日: 2012-05-23, 最終更新日: 2024-10-16)
主引用文献Ashwell, M.A.,Lapierre, J.M.,Brassard, C.,Bresciano, K.,Bull, C.,Cornell-Kennon, S.,Eathiraj, S.,France, D.S.,Hall, T.,Hill, J.,Kelleher, E.,Khanapurkar, S.,Kizer, D.,Koerner, S.,Link, J.,Liu, Y.,Makhija, S.,Moussa, M.,Namdev, N.,Nguyen, K.,Nicewonger, R.,Palma, R.,Szwaya, J.,Tandon, M.,Uppalapati, U.,Vensel, D.,Volak, L.P.,Volckova, E.,Westlund, N.,Wu, H.,Yang, R.Y.,Chan, T.C.
Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitors.
J.Med.Chem., 55:5291-5310, 2012
Cited by
PubMed Abstract: This paper describes the implementation of a biochemical and biophysical screening strategy to identify and optimize small molecule Akt1 inhibitors that act through a mechanism distinct from that observed for kinase domain ATP-competitive inhibitors. With the aid of an unphosphorylated Akt1 cocrystal structure of 12j solved at 2.25 Å, it was possible to confirm that as a consequence of binding these novel inhibitors, the ATP binding cleft contained a number of hydrophobic residues that occlude ATP binding as expected. These Akt inhibitors potently inhibit intracellular Akt activation and its downstream target (PRAS40) in vitro. In vivo pharmacodynamic and pharmacokinetic studies with two examples, 12e and 12j, showed the series to be similarly effective at inhibiting the activation of Akt and an additional downstream effector (p70S6) following oral dosing in mice.
PubMed: 22533986
DOI: 10.1021/jm300276x
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.19 Å)
構造検証レポート
Validation report summary of 4ejn
検証レポート(詳細版)ダウンロードをダウンロード

251801

件を2026-04-08に公開中

PDB statisticsPDBj update infoContact PDBjnumon